Azulfidine and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is reported as a side effect among people who take Azulfidine (sulfasalazine), especially for people who are female, 60+ old, also take Fosamax, and have Seasonal allergy.

The phase IV clinical study analyzes which people have Urinary incontinence when taking Azulfidine. It is created by eHealthMe based on reports of 7,893 people who have side effects when taking Azulfidine from the FDA, and is updated regularly.

What is Azulfidine?

Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 1,632 drugs and 2,518 conditions by eHealthMe. Check the latest studies of Urinary incontinence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 01, 2026

7,893 people reported to have side effects when taking Azulfidine.
Among them, 13 people (0.16%) have Urinary incontinence.

Could Azulfidine cause Urinary incontinence?

Among these 13 people:

What is the gender of people who have Urinary incontinence when taking Azulfidine? *

female: 100 %
male: 0.0 %

What is the age of people who have Urinary incontinence when taking Azulfidine? *

What are other drugs people take besides Azulfidine? *

What are other side effects people have besides Urinary incontinence? *

Nausea (feeling of having an urge to vomit): 8 people, 61.54%
Pneumonia: 7 people, 53.85%
Back Pain: 7 people, 53.85%
Rib Fracture: 7 people, 53.85%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 6 people, 46.15%
Rickets (softening of bones): 6 people, 46.15%
Calcium Deficiency (lack of calcium): 6 people, 46.15%
Pubis Fracture: 6 people, 46.15%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 6 people, 46.15%
Hip Fracture: 6 people, 46.15%

What are the existing conditions these people have? *

Seasonal Allergy (allergic condition due to certain season): 7 people, 53.85%
High Blood Pressure: 6 people, 46.15%
Osteoporosis (bones weak and more likely to break): 6 people, 46.15%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 46.15%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Swelling: 1 person, 7.69%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.69%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 7.69%
Breakthrough Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Azulfidine and have Urinary incontinence?

- Check whether Urinary incontinence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azulfidine:

Azulfidine (7,997 reports)

Browse all side effects of Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary incontinence:

Urinary incontinence (1,632 drugs)

Browse all the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,518 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.